Significant Accounting Policies (Tables)

9 Months Ended

Jan. 31, 2025

Accounting Policies [Abstract]

Schedule of the calculation of earnings (loss) per share, basic and diluted

The following table reflects these calculations. For the three and nine months ended January 31, 2024, all of the Company's potential common stock was considered anti-dilutive due to the Company's net losses in these periods.

 

	Three Months Ended January 31,				Nine Months Ended January 31,
(Dollars in Thousands)	2025		2024		2025		2024
Basic net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	4,495	$	(2,530)	$	6,536	$	(7,167)
Weighted Average common shares – basic	13,700,627		13,593,758		13,620,686		13,538,480
Basic net income (loss) per share	$	0.33	$	(0.19)	$	0.48	$	(0.53)
Diluted net income (loss) per share computation:
Net income (loss) attributable to common stockholders	$	4,495	$	(2,530)	$	6,536	$	(7,167)
Weighted Average common shares	13,700,627		13,593,758		13,620,686		13,538,480
Incremental shares from assumed exercise of stock options	664,277		—		512,026		—
Adjusted weighted average share – diluted	14,364,904		13,593,758		14,132,712		13,538,480
Diluted net income (loss) per share	$	0.31	$	(0.19)	$	0.46	$	(0.53)

Schedule of antidilutive securities excluded from earnings per share calculations

The following table reflects the total potential common stock instruments outstanding at January 31, 2025 and 2024 including those that could have an effect on the future computation of dilution per common share, had their effect not been anti-dilutive.

	January 31,
	2025	2024
Total common stock equivalents	499,480	1,903,747